indazoles has been researched along with Coronary Restenosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Basavarajaiah, S; Calabresi, M; Colombo, A; Guglielmotti, A; Lettieri, C; Limbruno, U; Picchi, A; Pierucci, D; Prati, F; Sciahbasi, A; Valgimigli, M | 1 |
Chang, YL; Guh, JH; Kuo, SC; Lee, FY; Liu, YN; Pan, SL; Peng, CY; Teng, CM | 1 |
1 trial(s) available for indazoles and Coronary Restenosis
Article | Year |
---|---|
A double-blind randomised study to evaluate the efficacy and safety of bindarit in preventing coronary stent restenosis.
Topics: Adolescent; Adult; Aged; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Double-Blind Method; Drug-Eluting Stents; Female; Humans; Indazoles; Male; Middle Aged; Percutaneous Coronary Intervention; Propionates; Treatment Outcome; Young Adult | 2016 |
1 other study(ies) available for indazoles and Coronary Restenosis
Article | Year |
---|---|
The indazole derivative YD-3 inhibits thrombin-induced vascular smooth muscle cell proliferation and attenuates intimal thickening after balloon injury.
Topics: Administration, Oral; Animals; Aorta, Thoracic; Arteriosclerosis; Blotting, Western; Catheterization; Cell Proliferation; Cells, Cultured; Coronary Restenosis; Dose-Response Relationship, Drug; Flavonoids; Immunohistochemistry; Indazoles; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Chemical; Muscle, Smooth, Vascular; Peptides; Phosphorylation; Protein Kinase Inhibitors; ras Proteins; Rats; Rats, Wistar; Receptor, PAR-1; Signal Transduction; Thrombin; Thymidine | 2004 |